ArticleMaterials today. Bio2026
Self-oxidatively crosslinked sprayable hydrogel for microenvironment remodeling and accelerated healing of recurrent aphthous ulcers.
Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recurrent aphthous ulcer (RAU) is a prevalent inflammatory disorder of the oral mucosa, characterized by a persistent "vicious cycle" of excessive oxidative stress, dysregulated immune responses, and impaired tissue regeneration. Effective clinical management remains challenging due to the dynamic and hydrated oral environment, which severely limits drug retention and multi-target therapeutic efficacy. Herein, we developed a multifunctional, sprayable hydrogel (PDS Gel) using a hierarchical "oxygen-limited initiation - oxygen-controlled progression" crosslinking strategy, integrating polygalacturonic acid (PGA), dopamine (DA), and salidroside-derived carbon dots (Sal-CDs). The PDS Gel achieves rapid in situ solidification and exhibits certain mucoadhesive properties, allowing attachment to the wet mucosal surface shortly after spraying. Mechanistically, the hydrogel exhibits potent reactive oxygen species (ROS) scavenging capacity and intrinsic antibacterial activity, effectively remodeling the pathological wound microenvironment. Crucially, PDS Gel promotes macrophage polarization from a pro-inflammatory M1 phenotype toward a pro-regenerative M2 phenotype, thereby suppressing excessive inflammatory cascades. Simultaneously, it restores fibroblast-mediated extracellular matrix (ECM) remodeling and enhances endothelial cell-driven angiogenesis. In vivo evaluations using both oral mucosal and full-thickness skin defect models demonstrate that PDS Gel significantly accelerates wound closure, facilitates epithelial reconstruction, and promotes orderly collagen deposition. Collectively, this self-oxidatively crosslinked immunomodulatory hydrogel provides a promising biomaterial paradigm for the precision therapy of RAU and other complex mucosal lesions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.